Literature DB >> 22461704

Hepatitis C virus seroprevalence in the Netherlands.

Henrike J Vriend1, Eline L M Op de Coul, Thijs J W van de Laar, Anouk T Urbanus, Fiona R M van der Klis, Hein J Boot.   

Abstract

A population-based anti-hepatitis C virus (HCV) prevalence is important for surveillance purposes and it provides an insight into the burden of disease. In The Netherlands, a recent HCV seroprevalence estimate is not available. This national population-based cross-sectional serosurvey (PIENTER-2) resulted in a weighted national HCV seroprevalence of 0.30% (95% confidence interval 0.05-0.55%). About 70% of the HCV positive individuals found were born in an HCV-endemic country.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22461704     DOI： 10.1093/eurpub/cks013

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN： 1101-1262            Impact factor:   3.367


  9 in total

1.  Detecting Hepatitis B and C by Combined Public Health and Primary Care Birth Cohort Testing.

Authors:  Jeanne Heil; Christian J P A Hoebe; Jochen W L Cals; Henriëtte L G Ter Waarbeek; Inge H M van Loo; Nicole H T M Dukers-Muijrers
Journal:  Ann Fam Med       Date:  2018-01       Impact factor: 5.166

Review 2.  Epidemiology and natural history of HCV infection.

Authors:  Behzad Hajarizadeh; Jason Grebely; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-02       Impact factor: 46.802

3.  The Spatial Distribution of Hepatitis C Virus Infections and Associated Determinants--An Application of a Geographically Weighted Poisson Regression for Evidence-Based Screening Interventions in Hotspots.

Authors:  Boris Kauhl; Jeanne Heil; Christian J P A Hoebe; Jürgen Schweikart; Thomas Krafft; Nicole H T M Dukers-Muijrers
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

4.  Hepatitis C virus seroprevalence and prevalence of chronic infection in the adult population in Ireland: a study of residual sera, April 2014 to February 2016.

Authors:  Patricia Garvey; Brian O'Grady; Geraldine Franzoni; Maeve Bolger; Katie Irwin Crosby; Jeff Connell; Deirdre Burke; Cillian De Gascun; Lelia Thornton
Journal:  Euro Surveill       Date:  2017-07-27

5.  Chronic hepatitis B and C infections in the Netherlands: estimated prevalence in risk groups and the general population.

Authors:  J Koopsen; J E van Steenbergen; J H Richardus; M Prins; E L M Op de Coul; E A Croes; J Heil; F R Zuure; I K Veldhuijzen
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

6.  Hepatitis C virus prevalence in The Netherlands: migrants account for most infections.

Authors:  H J Vriend; M G Van Veen; M Prins; A T Urbanus; H J Boot; E L M Op De Coul
Journal:  Epidemiol Infect       Date:  2012-09-11       Impact factor: 4.434

7.  Hepatitis E prevalence in a sexual high-risk population compared to the general population.

Authors:  Jeanne Heil; Christian J P A Hoebe; Inge H M van Loo; Jochen W L Cals; Geneviève A F S van Liere; Nicole H T M Dukers-Muijrers
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

Review 8.  Strategies for achieving viral hepatitis C micro-elimination in the Netherlands.

Authors:  P A M Kracht; J E Arends; K J van Erpecum; A Urbanus; J A Willemse; A I M Hoepelman; E A Croes
Journal:  Hepatol Med Policy       Date:  2018-09-29

9.  Estimating regional prevalence of chronic hepatitis C with a capture-recapture analysis.

Authors:  Patricia A M Kracht; Joop E Arends; Andy I M Hoepelman; Mirjam E E Kretzschmar
Journal:  BMC Infect Dis       Date:  2021-07-03       Impact factor: 3.090
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.